Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway

Virology

Volumn 444, Issue 1-2, 2013, Pages 45-54

  Garrison, Aura R ^a   Radoshitzky, Sheli R ^a   Kota, Krishna P ^a   Pegoraro, Gianluca ^a   Ruthel, Gordon ^a   Kuhn, Jens H ^b   Altamura, Louis A ^a   Kwilas, Steven A ^a   Bavari, Sina ^a   Haucke, Volker ^c   Schmaljohn, Connie S ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Bunyavirus; CCHF; Crimean Congo hemorrhagic fever; Nairovirus; Virus entry

Indexed keywords

CLATHRIN; RAB PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL VIABILITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; ENDOSOME; INFECTION RATE; INHIBITION KINETICS; MOLECULAR DYNAMICS; NAIRO VIRUS; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENTRY; VIRUS INACTIVATION;

BUNYAVIRUS; CCHF; CRIMEAN-CONGO HEMORRHAGIC FEVER; NAIROVIRUS; VIRUS ENTRY;

ADAPTOR PROTEIN COMPLEX 2; CLATHRIN; CLATHRIN-COATED VESICLES; ENDOCYTOSIS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HUMANS; HYDROGEN-ION CONCENTRATION; RAB GTP-BINDING PROTEINS; RAB5 GTP-BINDING PROTEINS; VIRUS INTERNALIZATION;

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; NAIROVIRUS; ORTHOBUNYAVIRUS;

EID: 84882889303     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.030     Document Type: Article

References (60)

1. Altamura L.A., Bertolotti-Ciarlet A., Teigler J., Paragas J., Schmaljohn C.S., Doms R.W. Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J. Virol. 2007, 81:6632-6642.
2. Battisti A.J., Chu Y.K., Chipman P.R., Kaufmann B., Jonsson C.B., Rossmann M.G. Structural studies of Hantaan virus. J. Virol. 2010, 85:835-841.
3. Bergeron E., Vincent M.J., Nichol S.T. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J. Virol. 2007, 81:13271-13276.
4. Bhattacharyya S., Hope T.J., Young J.A. Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology 2011, 419:1-9.
5. Blondeau F., Ritter B., Allaire P.D., Wasiak S., Girard M., Hussain N.K., Angers A., Legendre-Guillemin V., Roy L., Boismenu D., Kearney R.E., Bell A.W., Bergeron J.J., McPherson P.S. Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Natl. Acad. Sci. USA 2004, 101:3833-3838.
6. Bradley J.R., Johnson D.R., Pober J.S. Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J. Immunol. 1993, 150:5544-5555.
7. Carneiro F.A., Ferradosa A.S., Da Poian A.T. Low pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization. J. Biol. Chem. 2001, 276:62-67.
8. Carpentier J.L., Sawano F., Geiger D., Gorden P., Perrelet A., Orci L. Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates. J. Cell. Physiol. 1989, 138:519-526.
9. Choudhury A., Dominguez M., Puri V., Sharma D.K., Narita K., Wheatley C.L., Marks D.L., Pagano R.E. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 2002, 109:1541-1550.
10. Costin J.M., Jenwitheesuk E., Lok S.M., Hunsperger E., Conrads K.A., Fontaine K.A., Rees C.R., Rossmann M.G., Isern S., Samudrala R., Michael S.F. Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl. Trop. Dis. 2010, 4:e721.
11. Deborde S., Perret E., Gravotta D., Deora A., Salvarezza S., Schreiner R., Rodriguez-Boulan E. Clathrin is a key regulator of basolateral polarity. Nature 2008, 452:719-723.
12. Dutta D., Williamson C.D., Cole N.B., Donaldson J.G. Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS One 2012, 7:e45799.
13. Elferink J.G. Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. Biochem. Pharmacol. 1979, 28:965-968.
14. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr. Opin. Virol. 2012, 2:215-220.
15. Filone C.M., Heise M., Doms R.W., Bertolotti-Ciarlet A. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology 2006, 356:155-164.
16. Galloway C.J., Dean G.E., Marsh M., Rudnick G., Mellman I. Acidification of macrophage and fibroblast endocytic vesicles in vitro. Proc. Natl. Acad. Sci. USA 1983, 80:3334-3338.
17. Gruenberg J. Viruses and endosome membrane dynamics. Curr. Opin. Cell Biol. 2009, 21:582-588.
18. Harmon B., Schudel B.R., Maar D., Kozina C., Ikegami T., Tseng C.T., Negrete O.A. Rift Valley fever virus strain MP-12 enters mammalian host cells via caveolae-mediated endocytosis. J. Virol. 2012, 23:12954-12970.
19. Higa M.M., Petersen J., Hooper J., Doms R.W. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. Virology 2012, 423:134-142.
20. Hollidge B.S., Nedelsky N.B., Salzano M.V., Fraser J.W., Gonzalez-Scarano F., Soldan S.S. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J. Virol. 2012, 15:7988-8001.
21. Jin M., Park J., Lee S., Park B., Shin J., Song K.J., Ahn T.I., Hwang S.Y., Ahn B.Y., Ahn K. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 2002, 294:60-69.
22. Johannsdottir H.K., Mancini R., Kartenbeck J., Amato L., Helenius A. Host cell factors and functions involved in vesicular stomatitis virus entry. J. Virol. 2009, 83:440-453.
23. Khan M., Santhosh S.R., Tiwari M., Lakshmana Rao P.V., Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J. Med. Virol. 2010, 82:817-824.
24. Khetawat D., Broder C.C. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol. J. 2010, 7:312.
25. Kilby J.M., Hopkins S., Venetta T.M., DiMassimo B., Cloud G.A., Lee J.Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M.R., Nowak M.A., Shaw G.M., Saag M.S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 1998, 4:1302-1307.
26. Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int. J. Antimicrob. Agents. 2010, 36(Suppl. 1):S43-S46.
27. Ljosa V., Carpenter A.E. Introduction to the quantitative analysis of two-dimensional fluorescence microscopy images for cell-based screening. PLoS Comput. Biol. 2009, 5:e1000603.
28. Lozach P.Y., Kuhbacher A., Meier R., Mancini R., Bitto D., Bouloy M., Helenius A. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011, 10:75-88.
29. Lozach P.Y., Mancini R., Bitto D., Meier R., Oestereich L., Overby A.K., Pettersson R.F., Helenius A. Entry of bunyaviruses into mammalian cells. Cell Host Microbe 2010, 7:488-499.
30. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533.
31. Motley A., Bright N.A., Seaman M.N., Robinson M.S. Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol. 2003, 162:909-918.
32. Nicholson C.O., Costin J.M., Rowe D.K., Lin L., Jenwitheesuk E., Samudrala R., Isern S., Michael S.F. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro. Antiviral. Res. 2011, 89:71-74.
33. Overby A.K., Pettersson R.F., Grunewald K., Huiskonen J.T. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl. Acad. Sci. USA 2008, 105:2375-2379.
34. Panchal R.G., Kota K.P., Spurgers K.B., Ruthel G., Tran J.P., Boltz R.C., Bavari S. Development of high-content imaging assays for lethal viral pathogens. J. Biomol. Screen. 2010, 15:755-765.
35. Pasqual G., Rojek J.M., Masin M., Chatton J.Y., Kunz S. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog. 2011, 7:e1002232.
36. Pekosz A., Gonzalez-Scarano F. The extracellular domain of La Crosse virus G1 forms oligomers and undergoes pH-dependent conformational changes. Virology 1996, 225:243-247.
37. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Martin-Garcia J., Gonzalez-Scarano F. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology 2005, 338:121-132.
38. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Roth S.M., Martin-Garcia J., Gonzalez-Scarano F. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology 2007, 358:273-282.
39. Poh M.K., Yip A., Zhang S., Priestle J.P., Ma N.L., Smit J.M., Wilschut J., Shi P.Y., Wenk M.R., Schul W. A small molecule fusion inhibitor of dengue virus. Antiviral. Res. 2009, 84:260-266.
40. Royle S.J., Bright N.A., Lagnado L. Clathrin is required for the function of the mitotic spindle. Nature 2005, 434:1152-1157.
41. Saeed M.F., Kolokoltsov A.A., Albrecht T., Davey R.A. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 2010, 6:e1001110.
42. Sanchez A.J., Vincent M.J., Nichol S.T. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 2002, 76:7263-7275.
43. Santos R.I., Rodrigues A.H., Silva M.L., Mortara R.A., Rossi M.A., Jamur M.C., Oliver C., Arruda E. Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification. Virus. Res. 2008, 138:139-143.
44. Schelhaas M. Come in and take your coat off-how host cells provide endocytosis for virus entry. Cell. Microbiol. 2010, 12:1378-1388.
45. Schmaljohn C.S., Nichol S.T. Bunyaviridae. Fields Virology 2007, 1741-1789. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
46. Shariff A., Kangas J., Coelho L.P., Quinn S., Murphy R.F. Automated image analysis for high-content screening and analysis. J. Biomol. Screen. 2010, 15:726-734.
47. Sherman M.B., Freiberg A.N., Holbrook M.R., Watowich S.J. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology 2009, 387:11-15.
48. Sidira P., Maltezou H.C., Haidich A.B., Papa A. Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009-2010. Clin. Microbiol. Infect. 2011, 18:E16-19.
49. Simon M., Johansson C., Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 2009, 90:210-215.
50. Stenmark H., Parton R.G., Steele-Mortimer O., Lutcke A., Gruenberg J., Zerial M. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 1994, 13:1287-1296.
51. Stenmark H., Valencia A., Martinez O., Ullrich O., Goud B., Zerial M. Distinct structural elements of rab5 define its functional specificity. EMBO J. 1994, 13:575-583.
52. Synnes M., Prydz K., Lovdal T., Brech A., Berg T. Fluid phase endocytosis and galactosyl receptor-mediated endocytosis employ different early endosomes. Biochim. Biophys. Acta 1999, 1421:317-328.
53. Towner J.S., Paragas J., Dover J.E., Gupta M., Goldsmith C.S., Huggins J.W., Nichol S.T. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 2005, 332:20-27.
54. von Kleist L., Stahlschmidt W., Bulut H., Gromova K., Puchkov D., Robertson M.J., MacGregor K.A., Tomilin N., Pechstein A., Chau N., Chircop M., Sakoff J., von Kries J.P., Saenger W., Krausslich H.G., Shupliakov O., Robinson P.J., McCluskey A., Haucke V. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 2011, 146:471-484.
55. Vorou R., Pierroutsakos I.N., Maltezou H.C. Crimean-Congo hemorrhagic fever. Curr. Opin. Infect. Dis. 2007, 20:495-500.
56. Watanabe S., Hirose M., Miyazaki A., Tomono M., Takeuchi M., Kitamura T., Namihisa T. Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells. Lab. Invest. 1988, 59:214-218.
57. White J., Matlin K., Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J. Cell Biol. 1981, 89:674-679.
58. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral. Res. 2004, 64:145-160.
59. Wilson J.A., Hevey M., Bakken R., Guest S., Bray M., Schmaljohn A.L., Hart M.K. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000, 287:1664-1666.
60. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.